Detalles de la búsqueda
1.
The clinical relevance of fractional curettage in the diagnostic management of primary endometrial cancer.
Gynecol Obstet Invest
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38471484
2.
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.
Cell Mol Life Sci
; 79(12): 597, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399280
3.
Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification.
Int J Mol Sci
; 23(18)2022 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142803
4.
Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
Int J Cancer
; 146(4): 1086-1098, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31286496
5.
Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.
Cell Mol Life Sci
; 80(3): 64, 2023 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807766
6.
The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt.
Nanomedicine
; 20: 101983, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30940505
7.
Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer.
Cancer Commun (Lond)
; 44(1): 101-126, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140698
8.
Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors.
Cancers (Basel)
; 16(1)2023 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201534
9.
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily.
Eur J Med Chem
; 254: 115347, 2023 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094449
10.
Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.
Am J Pathol
; 179(4): 2091-9, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21839059
11.
The Role of DAPK1 in the Cell Cycle Regulation of Cervical Cancer Cells and in Response to Topotecan.
J Cancer
; 13(3): 728-743, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35154442
12.
A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1.
Oncogene
; 41(3): 372-386, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34759346
13.
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy.
Cancers (Basel)
; 14(22)2022 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428594
14.
The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells.
Cancers (Basel)
; 13(15)2021 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359562
15.
Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors.
J Med Chem
; 64(12): 8142-8160, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34086472
16.
The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression.
Front Oncol
; 10: 558932, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33117692
17.
Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability.
Neoplasia
; 21(4): 363-375, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851646
18.
The role of PLK1 in cancer exhibiting chromosomal instability.
Mol Cell Oncol
; 5(6): e1485539, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30525086
19.
Correction: A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1.
Oncogene
; 42(34): 2590, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488194
20.
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells.
Nat Commun
; 9(1): 1106, 2018 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29549256